<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04000828</url>
  </required_header>
  <id_info>
    <org_study_id>2019-14131</org_study_id>
    <nct_id>NCT04000828</nct_id>
  </id_info>
  <brief_title>Comparison of Sensimed Triggerfish (TF) 24 Hour Monitoring of the Eye in Glaucoma Patients Before and After Trabeculectomy</brief_title>
  <official_title>Comparison of Sensimed Triggerfish (TF) 24 Hour Monitoring of the Eye in Glaucoma Patients Before and After Trabeculectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johannes Gutenberg University Mainz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johannes Gutenberg University Mainz</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A 24 hour profile is recorded using Sensimed Triggerfish in glaucoma patients before and
      after Trabecuelctomy
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2019</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amplitude</measure>
    <time_frame>up to 14 weeks</time_frame>
    <description>Comparison of Amplitude between the preoperative Triggerfish Profile and the Triggerfish Profile three months after Trabeculectomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of other parameters</measure>
    <time_frame>up to 14 weeks</time_frame>
    <description>Correlation of IOP and Triggerfish Profile, Correlation of IOP, blood pressure and heart rate, Evaluation of 24 hours nyctohemeral rhythm of measurements before and after trabeculectomy</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>single Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>all patients receive the measurement with Sensimed Triggerfish</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placement of Sensimed Triggerfish</intervention_name>
    <description>Sensimed Triggerfish is placed on the corneal surface</description>
    <arm_group_label>single Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient must have the willingness and ability to provide signed informed consent

          -  Patient is able to comply with the study procedure

          -  Patient must be ≥ 18 years old

          -  Diagnosis of primary open angle glaucoma (EGS criteria) including pseudoexfoliation
             glaucoma/ normal tension glaucoma/ pigmentary glaucoma in the study eye

          -  planned trabeculectomy in the study eye

          -  in preparation for trabeculectomy, all preoperative IOP lowering medication has been
             replaced by Dorzolamid 20 mg/ml + Timolol 5mg/ml preservative free eye drops in the
             study eye for at least 28 days before Triggerfish® profile

          -  Patient has consented to be in the trial and signed informed consent is available
             before any study related procedures are carried out

          -  Visual Acuity of 20/200 or better in both eyes

          -  Ability of subject to understand the character and individual consequences of the
             study

        Exclusion Criteria:

          -  Subjects with contraindications for wearing contact lenses in the study eye

          -  secondary glaucoma in the study eye

          -  History of refractive surgery in the study eye

          -  History of intraocular surgery in the last three months in the study eye

          -  Severe dry eye syndrome as judged by the investigator in the study eye

          -  Keratoconus or other corneal abnormalities

          -  Any other abnormality in the study eye, that prevents the safe placement of the device
             after investigators decision

          -  Conjunctival or intraocular inflammation in the study eye

          -  Simultaneous participation in other clinical trials

          -  Previous IOP-lowering intervention in the study eye

          -  Current shift workers (applicable for at least 3 months)

          -  Transmeridian flight &lt; 2 months before screening (6 hours time shift)

          -  Subjects with pacemaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Katrin Lorenz, PD Dr. Dr.</last_name>
    <phone>00496131/174069</phone>
    <email>katrin.lorenz@unimedizin-mainz.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Beck, Dr.</last_name>
    <phone>00496131/177508</phone>
    <email>anna.beck@unimedizin-mainz.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinical Trial Site, Department of Ophthalmology, University Medical Center Johannes Gutenberg University Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katrin Lorenz, MD</last_name>
      <phone>0049 6131 17</phone>
      <phone_ext>4069</phone_ext>
      <email>katrin.lorenz@unimedizin-mainz.de</email>
    </contact>
    <contact_backup>
      <last_name>Anna Beck, MD</last_name>
      <phone>0049 6131 17</phone>
      <phone_ext>7508</phone_ext>
      <email>anna.beck@unimedizin-mainz.de</email>
    </contact_backup>
    <investigator>
      <last_name>Katrin Lorenz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 27, 2019</study_first_submitted>
  <study_first_submitted_qc>June 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2019</study_first_posted>
  <last_update_submitted>June 26, 2019</last_update_submitted>
  <last_update_submitted_qc>June 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johannes Gutenberg University Mainz</investigator_affiliation>
    <investigator_full_name>Katrin Lorenz</investigator_full_name>
    <investigator_title>Head of clinical trial site</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

